17 beta-hydroxysteroid dehydrogenase type 3 deficiency

Dehydroepiandrosterone comes into subsequent oxidative transformation with production of 16Alpha-hydroxydehydroepiandrosterone . This oxidation is catalyzed by Cytochrome P450, family 3, subfamily A, polypeptide 7 ( CYP3A7) [10] , [11] , [12] and Cytochrome P450, family 3, subfamily A, polypeptide 4 ( CYP3A4) [13] , [10] , [11] . Oxidative metabolite of this reaction as well as Dehydroepiandrosterone can be further sulfated by steroid sulfatase (microsomal), isozyme S ( STS ) [14] , [15] , [16] , [15] , [14] . Dehydroepiandrosterone and Dehydroepiandrosterone sulfate can be transformed into other compounds with hormonal activity, Androstendiol and Androstendiol sulfate , respectively. These two reactions are catalyzed by Hydroxysteroid (17-beta) dehydrogenase 1 ( HSD17B1) [17] , [18] , [17] , [18] , Hydroxysteroid (17-beta) dehydrogenase 2 ( HSD17B2) [19] , [20] , [20] , [21] , and Hydroxysteroid (17-beta) dehydrogenase 7 ( HSD17B7 ) [22] , [23] , [23] , [24] .

The LOINC® codes are copyright © 1994-2017, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at  https:///license/ . Additional information regarding LOINC® codes can be found at , including the LOINC Manual, which can be downloaded at /downloads/files/

17 beta-hydroxysteroid dehydrogenase type 3 deficiency

17 beta-hydroxysteroid dehydrogenase type 3 deficiency

Media:

17 beta-hydroxysteroid dehydrogenase type 3 deficiency17 beta-hydroxysteroid dehydrogenase type 3 deficiency17 beta-hydroxysteroid dehydrogenase type 3 deficiency17 beta-hydroxysteroid dehydrogenase type 3 deficiency17 beta-hydroxysteroid dehydrogenase type 3 deficiency

http://buy-steroids.org